CLEO DIAGNOSTICS LTD - Announcements

Market Cap $26.11M Add to my watchlist

Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal... Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal activities involve the development and patent of a blood test for the detection of ovarian cancer. It focuses on bringing to market a blood test for the early diagnosis of ovarian cancer based on the novel CXCL10 biomarker, which is produced early and at high levels by ovarian cancers but is largely absent in non-malignant disease. It is advancing the availability of its blood test, under a modular execution strategy, which is designed to address all ovarian cancer detection markets with specific tests, including surgical triage, recurrence, high risk, and early-stage screening. It has developed a three-phased product development strategy that delivers three related tests for ovarian cancer detection: Triage Test, Recurrence Test, and Screening Test. Triage Test is a pre-surgical test to determine the likelihood that a pre-surgical ovarian mass in a patient not yet referred to an oncologist, is malignant.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

COV	Cleo Commences US Regulatory Process with FDA	PRICE SENSITIVE	26/06/24	2.75MB	Share
COV	Application for quotation of securities - COV		24/06/24	14.19KB	Share
COV	Restricted securities to be released from escrow		14/06/24	329.6KB	Share
COV	COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark	PRICE SENSITIVE	29/05/24	2.8MB	Share
COV	Quarterly activities and cashflow report	PRICE SENSITIVE	29/04/24	4.39MB	Share
COV	COV Appoints CRO to Manage US Ovarian Cancer Clinical Trials	PRICE SENSITIVE	11/04/24	2.78MB	Share
COV	CLEO Appoints Partner to Commence U.S. Market Access Program	PRICE SENSITIVE	02/04/24	2.79MB	Share
COV	Peer-Review Supports CLEOs Ovarian Cancer Detection Tech	PRICE SENSITIVE	25/03/24	2.79MB	Share
COV	Appendix 4D and Half Yearly Accounts	PRICE SENSITIVE	29/02/24	747.87KB	Share
COV	Corporate Presentation February 2024		20/02/24	2.32MB	Share
COV	Cleo Completes Design Transfer	PRICE SENSITIVE	12/02/24	2.7MB	Share
COV	Quarterly activities and cashflow report	PRICE SENSITIVE	31/01/24	996.59KB	Share
COV	Results of Annual General Meeting		22/11/23	400.96KB	Share
COV	Application for quotation of securities - COV		06/11/23	28.3KB	Share
COV	Completion of First Triage Test Clinical Validation Study	PRICE SENSITIVE	06/11/23	2.96MB	Share
COV	Trading Halt	PRICE SENSITIVE	03/11/23	714.91KB	Share
COV	Pause in Trading	PRICE SENSITIVE	03/11/23	115.61KB	Share
COV	Quarterly activities and cashflow report	PRICE SENSITIVE	30/10/23	4.67MB	Share
COV	Restricted securities to be released from escrow		27/10/23	331.54KB	Share
COV	Application for quotation of securities - COV		13/10/23	30.46KB	Share
COV	Cleo Delivers Early Progress on Development Program	PRICE SENSITIVE	09/10/23	3.17MB	Share
COV	Restricted securities to be released from escrow		06/10/23	331.89KB	Share
COV	Letter to Shareholders		05/10/23	307.45KB	Share
COV	Notice of Annual General Meeting/Proxy Form		05/10/23	515.34KB	Share
COV	Cleo Enhances Board Capacity		02/10/23	2.68MB	Share
COV	Appendix 4G and Corporate Governance Statement		27/09/23	445.92KB	Share
COV	Annual Report to shareholders		27/09/23	1.54MB	Share
COV	Notice Required Under ASX Listing Rule 3.13.1		22/09/23	310.07KB	Share
COV	Change of Registry Address		21/09/23	321.78KB	Share
COV	Application for quotation of securities - COV		19/09/23	30.19KB	Share
COV	Restricted securities to be released from escrow		12/09/23	352.09KB	Share
COV	Letter from the CEO to Shareholders		01/09/23	2.74MB	Share
COV	Appendix 4E and Preliminary Financial Report	PRICE SENSITIVE	31/08/23	694.36KB	Share
COV	CLEO Granted U.S. Patent for Novel Ovarian Cancer Biomarker		22/08/23	435.58KB	Share
COV	Initial Directors Interest Notices x 5		21/08/23	244.88KB	Share
COV	Notice of initial substantial holders x 3		21/08/23	797.37KB	Share
COV	Pre-Quotation Notice		18/08/23	398.21KB	Share
COV	Distribution Schedule		18/08/23	51.75KB	Share
COV	Top 20 Holders		18/08/23	63.74KB	Share
COV	Securities Trading Policy		18/08/23	176.54KB	Share
COV	Employee Securities Incentive Plan		18/08/23	511.56KB	Share
COV	Interim Report 31 December 2022		18/08/23	741.87KB	Share
COV	Annual Report 30 June 2022		18/08/23	752.4KB	Share
COV	Constitution		18/08/23	451.66KB	Share
COV	Replacement Prospectus		18/08/23	3.29MB	Share
COV	Information Form and Checklist		18/08/23	343.81KB	Share
COV	Appendix 1A		18/08/23	59.51KB	Share
COV	ASX Notice - Admission and Quotation		18/08/23	442.54KB	Share
COV	Removal from Official List (cob 24 02 2010)		23/02/10	30.46KB	Share
COV +TGF	Amended ASX Circular - Scheme of Arrangement		12/02/10	48.22KB	Share
COV	Suspension from official quotation	PRICE SENSITIVE	11/02/10	30.71KB	Share
COV +TGF	Court Order Lodged with ASIC		10/02/10	117.27KB	Share
COV +TGF	Federal Court Approves Scheme		09/02/10	120.4KB	Share
COV +TGF	ASX Circular - Scheme of Arrangement		08/02/10	48.19KB	Share
COV +TGF	Results of General Meeting to Approve Scheme		28/01/10	126.92KB	Share
COV	Quarterly Report and Appendix 5B	PRICE SENSITIVE	25/01/10	2.51MB	Share
COV +TGF	Scheme Booklet and Notice of Scheme Meeting		24/12/09	15.92MB	Share
COV +TGF	Update on Merger with Tianshan Goldfields Limited		22/12/09	137.97KB	Share
COV +TGF	Corvette Issues Second Convertible Note		18/12/09	89.6KB	Share
COV +TGF	Corvette Issues Second Convertible Note	PRICE SENSITIVE	18/12/09	67.46KB	Share
COV	Presentation to Gold Investor Forum, Sydney, 7 Dec 09		07/12/09	3.05MB	Share
COV +TGF	$60M Merger Agreement Executed		27/11/09	97.38KB	Share
COV +TGF	Tianshan and Corvette sign Merger Implementation Agreement		27/11/09	136.37KB	Share
COV	Results of Annual General Meeting		26/11/09	143.67KB	Share
COV	AGM Presentation		24/11/09	2.18MB	Share
COV	Appendix 3B - Issue of Options		20/11/09	66.94KB	Share
COV	Merger Agreement		17/11/09	94.13KB	Share
COV +TGF	Tianshan and Corvette Agree to AU$60M Merger	PRICE SENSITIVE	17/11/09	98.62KB	Share
COV	Diamond Core Drilling	PRICE SENSITIVE	03/11/09	441.9KB	Share
COV	Annual Report to Shareholders		02/11/09	1.33MB	Share
COV	Activities Report and Appendix 5B	PRICE SENSITIVE	30/10/09	1.99MB	Share
COV	Notice of Annual General Meeting		23/10/09	187.92KB	Share
COV	Tianshan issues A$1M Convertible Note to Corvette Resources		22/10/09	98.34KB	Share
COV	Convertible Note Issued	PRICE SENSITIVE	22/10/09	88.95KB	Share
COV	High Grade Gold Discovery	PRICE SENSITIVE	20/10/09	546.72KB	Share
COV	Appointment of Company Secretary		02/10/09	100.09KB	Share
COV	Annual Report to shareholders		29/09/09	3MB	Share
COV	Change of Address and Contact Details		24/09/09	257.53KB	Share
COV	Investor Presentation		23/09/09	2.74MB	Share
COV	Two New Gold Zones at Corvette	PRICE SENSITIVE	31/08/09	584.86KB	Share
COV	Target Statement		21/08/09	4.89MB	Share
COV	Quarterly Activities Report	PRICE SENSITIVE	30/07/09	676.18KB	Share
COV	Significant Intersections of High Grade Gold at Stingray	PRICE SENSITIVE	28/07/09	580.45KB	Share
COV	Awarded EIS Drilling Grant Funding	PRICE SENSITIVE	29/06/09	274.67KB	Share
COV	High Grade Gold Intersection from RC Drilling at Corvette	PRICE SENSITIVE	25/06/09	379.95KB	Share
COV	Corvette and CSIRO commence Research Programme	PRICE SENSITIVE	19/05/09	132.38KB	Share
COV	Presentation to Gold Investor Forum		13/05/09	3.58MB	Share
COV	Replacement Appendix 3Y Change in Directors Interests		12/05/09	77.21KB	Share
COV	Appendix 3B Release from Escrow		12/05/09	81.61KB	Share
COV	Grant of Options to Non-Executive Directors		05/05/09	275.12KB	Share
COV	Change of Director's Interest Notice		01/05/09	28.17KB	Share
COV	Quarterly Activities and Cashflow Reports	PRICE SENSITIVE	22/04/09	2.75MB	Share
COV	Change of Director's Interest Notice		14/04/09	13.81KB	Share
COV	Broker Presentation (Amended)		23/03/09	2.69MB	Share
COV	Broker Presentation		23/03/09	3.98MB	Share
COV	Change of Director's Interest Notice		20/03/09	28.29KB	Share
COV	Corvette Intersects 15g/t gold	PRICE SENSITIVE	19/03/09	670.17KB	Share
COV	Half Yearly Accounts	PRICE SENSITIVE	11/03/09	801.88KB	Share
COV	RC Drilling Intersects Gold along 8 km Structure	PRICE SENSITIVE	05/03/09	592.38KB	Share
COV	Initial Director's Interest Notice		27/02/09	25.41KB	Share

COV Cleo Commences US Regulatory Process with FDA
26/06/24	PRICE SENSITIVE	2.75MB	Share
COV Application for quotation of securities - COV
24/06/24		14.19KB	Share
COV Restricted securities to be released from escrow
14/06/24		329.6KB	Share
COV COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark
29/05/24	PRICE SENSITIVE	2.8MB	Share
COV Quarterly activities and cashflow report
29/04/24	PRICE SENSITIVE	4.39MB	Share
COV COV Appoints CRO to Manage US Ovarian Cancer Clinical Trials
11/04/24	PRICE SENSITIVE	2.78MB	Share
COV CLEO Appoints Partner to Commence U.S. Market Access Program
02/04/24	PRICE SENSITIVE	2.79MB	Share
COV Peer-Review Supports CLEOs Ovarian Cancer Detection Tech
25/03/24	PRICE SENSITIVE	2.79MB	Share
COV Appendix 4D and Half Yearly Accounts
29/02/24	PRICE SENSITIVE	747.87KB	Share
COV Corporate Presentation February 2024
20/02/24		2.32MB	Share
COV Cleo Completes Design Transfer
12/02/24	PRICE SENSITIVE	2.7MB	Share
COV Quarterly activities and cashflow report
31/01/24	PRICE SENSITIVE	996.59KB	Share
COV Results of Annual General Meeting
22/11/23		400.96KB	Share
COV Application for quotation of securities - COV
06/11/23		28.3KB	Share
COV Completion of First Triage Test Clinical Validation Study
06/11/23	PRICE SENSITIVE	2.96MB	Share
COV Trading Halt
03/11/23	PRICE SENSITIVE	714.91KB	Share
COV Pause in Trading
03/11/23	PRICE SENSITIVE	115.61KB	Share
COV Quarterly activities and cashflow report
30/10/23	PRICE SENSITIVE	4.67MB	Share
COV Restricted securities to be released from escrow
27/10/23		331.54KB	Share
COV Application for quotation of securities - COV
13/10/23		30.46KB	Share
COV Cleo Delivers Early Progress on Development Program
09/10/23	PRICE SENSITIVE	3.17MB	Share
COV Restricted securities to be released from escrow
06/10/23		331.89KB	Share
COV Letter to Shareholders
05/10/23		307.45KB	Share
COV Notice of Annual General Meeting/Proxy Form
05/10/23		515.34KB	Share
COV Cleo Enhances Board Capacity
02/10/23		2.68MB	Share
COV Appendix 4G and Corporate Governance Statement
27/09/23		445.92KB	Share
COV Annual Report to shareholders
27/09/23		1.54MB	Share
COV Notice Required Under ASX Listing Rule 3.13.1
22/09/23		310.07KB	Share
COV Change of Registry Address
21/09/23		321.78KB	Share
COV Application for quotation of securities - COV
19/09/23		30.19KB	Share
COV Restricted securities to be released from escrow
12/09/23		352.09KB	Share
COV Letter from the CEO to Shareholders
01/09/23		2.74MB	Share
COV Appendix 4E and Preliminary Financial Report
31/08/23	PRICE SENSITIVE	694.36KB	Share
COV CLEO Granted U.S. Patent for Novel Ovarian Cancer Biomarker
22/08/23		435.58KB	Share
COV Initial Directors Interest Notices x 5
21/08/23		244.88KB	Share
COV Notice of initial substantial holders x 3
21/08/23		797.37KB	Share
COV Pre-Quotation Notice
18/08/23		398.21KB	Share
COV Distribution Schedule
18/08/23		51.75KB	Share
COV Top 20 Holders
18/08/23		63.74KB	Share
COV Securities Trading Policy
18/08/23		176.54KB	Share
COV Employee Securities Incentive Plan
18/08/23		511.56KB	Share
COV Interim Report 31 December 2022
18/08/23		741.87KB	Share
COV Annual Report 30 June 2022
18/08/23		752.4KB	Share
COV Constitution
18/08/23		451.66KB	Share
COV Replacement Prospectus
18/08/23		3.29MB	Share
COV Information Form and Checklist
18/08/23		343.81KB	Share
COV Appendix 1A
18/08/23		59.51KB	Share
COV ASX Notice - Admission and Quotation
18/08/23		442.54KB	Share
COVRemoval from Official List (cob 24 02 2010)
23/02/10		30.46KB	Share
COV +TGFAmended ASX Circular - Scheme of Arrangement
12/02/10		48.22KB	Share
COVSuspension from official quotation
11/02/10	PRICE SENSITIVE	30.71KB	Share
COV +TGFCourt Order Lodged with ASIC
10/02/10		117.27KB	Share
COV +TGFFederal Court Approves Scheme
09/02/10		120.4KB	Share
COV +TGFASX Circular - Scheme of Arrangement
08/02/10		48.19KB	Share
COV +TGFResults of General Meeting to Approve Scheme
28/01/10		126.92KB	Share
COVQuarterly Report and Appendix 5B
25/01/10	PRICE SENSITIVE	2.51MB	Share
COV +TGFScheme Booklet and Notice of Scheme Meeting
24/12/09		15.92MB	Share
COV +TGFUpdate on Merger with Tianshan Goldfields Limited
22/12/09		137.97KB	Share
COV +TGFCorvette Issues Second Convertible Note
18/12/09		89.6KB	Share
COV +TGFCorvette Issues Second Convertible Note
18/12/09	PRICE SENSITIVE	67.46KB	Share
COVPresentation to Gold Investor Forum, Sydney, 7 Dec 09
07/12/09		3.05MB	Share
COV +TGF$60M Merger Agreement Executed
27/11/09		97.38KB	Share
COV +TGFTianshan and Corvette sign Merger Implementation Agreement
27/11/09		136.37KB	Share
COVResults of Annual General Meeting
26/11/09		143.67KB	Share
COVAGM Presentation
24/11/09		2.18MB	Share
COVAppendix 3B - Issue of Options
20/11/09		66.94KB	Share
COVMerger Agreement
17/11/09		94.13KB	Share
COV +TGFTianshan and Corvette Agree to AU$60M Merger
17/11/09	PRICE SENSITIVE	98.62KB	Share
COVDiamond Core Drilling
03/11/09	PRICE SENSITIVE	441.9KB	Share
COVAnnual Report to Shareholders
02/11/09		1.33MB	Share
COVActivities Report and Appendix 5B
30/10/09	PRICE SENSITIVE	1.99MB	Share
COVNotice of Annual General Meeting
23/10/09		187.92KB	Share
COVTianshan issues A$1M Convertible Note to Corvette Resources
22/10/09		98.34KB	Share
COVConvertible Note Issued
22/10/09	PRICE SENSITIVE	88.95KB	Share
COVHigh Grade Gold Discovery
20/10/09	PRICE SENSITIVE	546.72KB	Share
COVAppointment of Company Secretary
02/10/09		100.09KB	Share
COVAnnual Report to shareholders
29/09/09		3MB	Share
COVChange of Address and Contact Details
24/09/09		257.53KB	Share
COVInvestor Presentation
23/09/09		2.74MB	Share
COVTwo New Gold Zones at Corvette
31/08/09	PRICE SENSITIVE	584.86KB	Share
COVTarget Statement
21/08/09		4.89MB	Share
COVQuarterly Activities Report
30/07/09	PRICE SENSITIVE	676.18KB	Share
COVSignificant Intersections of High Grade Gold at Stingray
28/07/09	PRICE SENSITIVE	580.45KB	Share
COVAwarded EIS Drilling Grant Funding
29/06/09	PRICE SENSITIVE	274.67KB	Share
COVHigh Grade Gold Intersection from RC Drilling at Corvette
25/06/09	PRICE SENSITIVE	379.95KB	Share
COVCorvette and CSIRO commence Research Programme
19/05/09	PRICE SENSITIVE	132.38KB	Share
COVPresentation to Gold Investor Forum
13/05/09		3.58MB	Share
COVReplacement Appendix 3Y Change in Directors Interests
12/05/09		77.21KB	Share
COVAppendix 3B Release from Escrow
12/05/09		81.61KB	Share
COVGrant of Options to Non-Executive Directors
05/05/09		275.12KB	Share
COVChange of Director's Interest Notice
01/05/09		28.17KB	Share
COVQuarterly Activities and Cashflow Reports
22/04/09	PRICE SENSITIVE	2.75MB	Share
COVChange of Director's Interest Notice
14/04/09		13.81KB	Share
COVBroker Presentation (Amended)
23/03/09		2.69MB	Share
COVBroker Presentation
23/03/09		3.98MB	Share
COVChange of Director's Interest Notice
20/03/09		28.29KB	Share
COVCorvette Intersects 15g/t gold
19/03/09	PRICE SENSITIVE	670.17KB	Share
COVHalf Yearly Accounts
11/03/09	PRICE SENSITIVE	801.88KB	Share
COVRC Drilling Intersects Gold along 8 km Structure
05/03/09	PRICE SENSITIVE	592.38KB	Share
COVInitial Director's Interest Notice
27/02/09		25.41KB	Share

REFRESH

(20min delay)
Last 32.0¢		Change -0.015(4.48%)		Mkt cap ! $26.11M

Open	High	Low	Value	Volume
32.5¢	32.5¢	31.0¢	$70.84K	222.8K

Buyers (Bids)

No.	Vol.	Price($)
1	10000	31.5¢

Sellers (Offers)

Price($)	Vol.	No.
34.0¢	29329	2

View Market Depth

No.	Vol.	Price($)
1	10000	0.315
3	19128	0.310
3	41569	0.305
5	68249	0.300
1	26685	0.295

Price($)	Vol.	No.
0.340	29329	2
0.370	26664	1
0.380	20212	1
0.390	27129	1
0.395	15000	1

Last trade - 15.00pm 22/07/2024 (20 minute delay)


Last 32.0¢		Change -0.015 ( 4.48 %)
Open	High	Low	Volume
32.0¢	32.0¢	31.5¢	10992
Last updated 10.46am 22/07/2024 ?

COV (ASX) Chart

CLEO DIAGNOSTICS LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available